Ascendiant Capital Maintains Buy on Cerenome, Lowers Price Target to $43

Benzinga Newsdesk www.benzinga.com Negative 77.5%

Neg 77.5% Neu 0% Pos 0%

Ascendiant Capital analyst Edward Woo maintains Cerenome (NASDAQ:CNSY) with a Buy and lowers the price target from $57 to $43.